Terminalia Gum as a Directly Compressible Excipient for Controlled Drug Delivery
- 266 Downloads
The exudates from the incised trunk of Terminalia randii has been evaluated as controlled release excipient in comparison with xanthan gum and hydroxypropylmethylcellulose (HPMC) using carvedilol (water insoluble) and theophylline (water soluble) as model drugs. Matrix tablets were prepared by direct compression and the effects of polymer concentration and excipients—spray dried lactose, microcrystalline cellulose and dicalcium phosphate dihydrate on the mechanical (crushing strength (CS) friability (F) and crushing strength–friability ratio (CSFR)) and drug release properties of the matrix tablets were evaluated. The drug release data were fitted into different release kinetics equations to determine the drug release mechanism(s) from the matrix tablets. The results showed that the CS and CSFR increased with increase in polymer concentration while F decreased. The ranking of CS and CSFR was HPMC > terminalia > xanthan while the ranking was reverse for F. The ranking for t 25 (i.e. time for 25% drug release) at a polymer concentration of 60% was xanthan > terminalia = HPMC. The dissolution time, t 25, of theophylline matrices was significantly lower (p < 0.001) than those of carvedilol matrix tablets. Drug release from the matrices was by swelling, diffusion and erosion. The mechanical and drug release properties of the tablets were significantly (p < 0.05) dependent on the type and concentration of polymer and excipients used with the release mechanisms varying from Fickian to anomalous. Terminalia gum compared favourably with standard polymers when used in controlled release matrices and could serve as a suitable alternative to the standard polymers in drug delivery.
Key wordsexcipients hydroxypropylmethylcellulose matrix tablets terminalia gum xanthan gum
We wish to acknowledge the India Science Academy for an INSA-TATA Fellowship awarded to O. A. Bamiro. We also thank Daman Ghai, Honey Goel and Gupreet Singh for their assistance during the study.
- 6.Biswas BK, Islam MDS, Begum F, Rouf AS. In vitro release kinetic study of esomeprazole magnesium from methocel K15M and methocel K100 LVCR matrix tablets. Dhaka Univ J Pharm Sci. 2008;7(1):39–45.Google Scholar
- 8.Shanmugasundaram S, Dhandapani NV, Rajendran A, Kumaraswamy S, Bhojraj S. Formulation of sodium alginate nanospheres containing amphotericin B for the treatment of systemic candidiasis. Trop J Pharm Res. 2007;6(1):653–9.Google Scholar
- 10.Bamiro OA, Sinha VR, Kumar R, Odeku OA. Characterization and evaluation of Terminalia randii gum as a binder in carvedilol tablet formulation. Acta Pharm Sci. 2010;52:254–62.Google Scholar
- 18.British Pharmacopoeia. 2004; Her Majesty Stationary Office, London, UKGoogle Scholar
- 21.Sandip BT, Krishna MT, Raveendra PM, Mehta PR, Chowdary PB. Controlled release formulation of tramadol hydrochloride using hydro-philic and hydrophobic matrix system. AAPS PharmSciTech 2003; 4 (3): Article 31.Google Scholar
- 24.Shah VP, Tsong Y, Sathe P. In vitro dissolution profile comparison—statistics and analysis of the similarity factor f2. Pharm Res. 1998;15:880–96.Google Scholar
- 28.Colombo P, Santi P, Bettini R, Brazel CS, Peppas NA. Drug release from swelling-controlled systems. In: Wise DL, editor. Handbook of pharmaceutical controlled release technology. New York: Marcel Dekker; 2000. p. 183–209.Google Scholar
- 30.Russo LI, Ghaly ES. Drug release from Carbopol 934 matrices. P R Health Sci J. 2002;19:131–7.Google Scholar